Author:
Yuda Sayako,Maruyama Dai,Maeshima Akiko Miyagi,Makita Shinichi,Kitahara Hideaki,Miyamoto Ken-ichi,Fukuhara Suguru,Munakata Wataru,Suzuki Tatsuya,Kobayashi Yukio,Tajima Kinuko,Taniguchi Hirokazu,Tobinai Kensei
Funder
The National Cancer Center Research and Development Fund
The Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference18 articles.
1. Horning SJ, Rosenberg S (1984) The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med 311:1471–1475. doi: 10.1056/nejm198412063112303
2. Young RC, Longo DL, Glatstein E, Ihde DC, Jaffe ES, DeVita VT Jr (1988) The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Semin Oncol 25(2 Suppl 2):11–16
3. Horning SJ (1993) Natural history of and therapy for the indolent non-Hodgkin’s lymphomas. Semin Oncol 20(5 Suppl 5):75–88
4. Brice P, Bastion Y, Lepage E, Brousse N, Haioun C, Moreau P, Straetmans N, Tilly H, Tabah I, Solal-Celigny P (1997) Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d’Etude des Lymphomes Folliculaires. Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 15:1110–1117
5. Ardeshna KM, Smith P, Norton A, Hancock BW, Hoskin PJ, MacLennan KA, Marcus RE, Jelliffe A, Hudson GV, Linch DC (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet 362:516–522. doi: 10.1016/s0140-6736(03)14110-4
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献